BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25533467)

  • 1. A mutation within the extended X loop abolished substrate-induced ATPase activity of the human liver ATP-binding cassette (ABC) transporter MDR3.
    Kluth M; Stindt J; Dröge C; Linnemann D; Kubitz R; Schmitt L
    J Biol Chem; 2015 Feb; 290(8):4896-4907. PubMed ID: 25533467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detergent screening and purification of the human liver ABC transporters BSEP (ABCB11) and MDR3 (ABCB4) expressed in the yeast Pichia pastoris.
    Ellinger P; Kluth M; Stindt J; Smits SH; Schmitt L
    PLoS One; 2013; 8(4):e60620. PubMed ID: 23593265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCB4/MDR3 in health and disease - at the crossroads of biochemistry and medicine.
    Prescher M; Kroll T; Schmitt L
    Biol Chem; 2019 Sep; 400(10):1245-1259. PubMed ID: 30730833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking.
    Dixon PH; Weerasekera N; Linton KJ; Donaldson O; Chambers J; Egginton E; Weaver J; Nelson-Piercy C; de Swiet M; Warnes G; Elias E; Higgins CF; Johnston DG; McCarthy MI; Williamson C
    Hum Mol Genet; 2000 May; 9(8):1209-17. PubMed ID: 10767346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
    Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
    J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in either nucleotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites.
    Urbatsch IL; Beaudet L; Carrier I; Gros P
    Biochemistry; 1998 Mar; 37(13):4592-602. PubMed ID: 9521779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the role of glutamine-471 and glutamine-1114 in the two catalytic sites of P-glycoprotein.
    Urbatsch IL; Gimi K; Wilke-Mounts S; Senior AE
    Biochemistry; 2000 Oct; 39(39):11921-7. PubMed ID: 11009605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histidine-loop is essential for transport activity of human MDR3. A novel mutation of MDR3 in a patient with progressive familial intrahepatic cholestasis type 3.
    Dzagania T; Engelmann G; Häussinger D; Schmitt L; Flechtenmacher C; Rtskhiladze I; Kubitz R
    Gene; 2012 Sep; 506(1):141-5. PubMed ID: 22766396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.
    Andress EJ; Nicolaou M; McGeoghan F; Linton KJ
    Cell Mol Life Sci; 2017 Jul; 74(13):2513-2524. PubMed ID: 28220208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
    Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
    Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy.
    Pauli-Magnus C; Lang T; Meier Y; Zodan-Marin T; Jung D; Breymann C; Zimmermann R; Kenngott S; Beuers U; Reichel C; Kerb R; Penger A; Meier PJ; Kullak-Ublick GA
    Pharmacogenetics; 2004 Feb; 14(2):91-102. PubMed ID: 15077010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of conserved carboxylate residues in the nucleotide binding sites of P-glycoprotein.
    Urbatsch IL; Julien M; Carrier I; Rousseau ME; Cayrol R; Gros P
    Biochemistry; 2000 Nov; 39(46):14138-49. PubMed ID: 11087362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein.
    Chufan EE; Kapoor K; Ambudkar SV
    Biochem Pharmacol; 2016 Feb; 101():40-53. PubMed ID: 26686578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a credit-card-swipe mechanism in the human PC floppase ABCB4.
    Prescher M; Bonus M; Stindt J; Keitel-Anselmino V; Smits SHJ; Gohlke H; Schmitt L
    Structure; 2021 Oct; 29(10):1144-1155.e5. PubMed ID: 34107287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monomeric bile acids modulate the ATPase activity of detergent-solubilized ABCB4/MDR3.
    Kroll T; Smits SHJ; Schmitt L
    J Lipid Res; 2021; 62():100087. PubMed ID: 34022183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of ABCB4/MDR3 ATPase activity requires an intact phosphatidylcholine lipid.
    Prescher M; Smits SHJ; Schmitt L
    J Lipid Res; 2020 Dec; 61(12):1605-1616. PubMed ID: 32917728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations define cross-talk between the N-terminal nucleotide-binding domain and transmembrane helix-2 of the yeast multidrug transporter Pdr5: possible conservation of a signaling interface for coupling ATP hydrolysis to drug transport.
    Sauna ZE; Bohn SS; Rutledge R; Dougherty MP; Cronin S; May L; Xia D; Ambudkar SV; Golin J
    J Biol Chem; 2008 Dec; 283(50):35010-22. PubMed ID: 18842589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3.
    Park HJ; Kim TH; Kim SW; Noh SH; Cho KJ; Choi C; Kwon EY; Choi YJ; Gee HY; Choi JH
    Sci Rep; 2016 Jun; 6():26872. PubMed ID: 27256251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis.
    de Vree JM; Jacquemin E; Sturm E; Cresteil D; Bosma PJ; Aten J; Deleuze JF; Desrochers M; Burdelski M; Bernard O; Oude Elferink RP; Hadchouel M
    Proc Natl Acad Sci U S A; 1998 Jan; 95(1):282-7. PubMed ID: 9419367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional consequences of mutations in the conserved 'signature sequence' of the ATP-binding-cassette protein MalK.
    Schmees G; Stein A; Hunke S; Landmesser H; Schneider E
    Eur J Biochem; 1999 Dec; 266(2):420-30. PubMed ID: 10561582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.